Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
Clinical trial NCT04952597 · COMPLETED
Trial details
- NCT number
- NCT04952597
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2023-07-26
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.